| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Liu Dongfang | CHIEF MEDICAL OFFICER | C/O NUVATION BIO INC., 1500 BROADWAY, SUITE 1401, NEW YORK | /s/ Stephen Dang, Attorney-in-Fact | 24 Nov 2025 | 0001937915 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | NUVB | Class A Common Stock | Options Exercise | $37,400 | +20,000 | +111% | $1.87 | 38,000 | 20 Nov 2025 | Direct | |
| transaction | NUVB | Class A Common Stock | Sale | $140,074 | -20,000 | -53% | $7.00 | 18,000 | 20 Nov 2025 | Direct | F1 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | NUVB | Stock Option (Right to Buy) | Options Exercise | $0 | -20,000 | -4.3% | $0.000000 | 450,000 | 20 Nov 2025 | Class A Common Stock | 20,000 | $1.87 | Direct | F2 |
| Id | Content |
|---|---|
| F1 | Price reported is a weighted-average sales price. The shares were sold at prices ranging from $7.00 to $7.005. The Reporting Person will provide, upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
| F2 | Option vested as to 25% on the one year anniversary of 2/29/2024, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date. |